awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38681598-0EEF0B4F-FDC8-491E-AAF4-BE62FEF84EF9
Q38681598-0EEF0B4F-FDC8-491E-AAF4-BE62FEF84EF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38681598-0EEF0B4F-FDC8-491E-AAF4-BE62FEF84EF9
Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.
P2860
Q38681598-0EEF0B4F-FDC8-491E-AAF4-BE62FEF84EF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38681598-0EEF0B4F-FDC8-491E-AAF4-BE62FEF84EF9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53bed3351bfedbaf6510132c3c39c7251d45f348
P2860
Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.